Access the full text.
Sign up today, get DeepDyve free for 14 days.
T. Bongartz, A. Sutton, M. Sweeting, I. Buchan, E. Matteson, V. Montori (2006)
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.JAMA, 295 19
J. Parker, K. Smarr, S. Buckelew, Reneé Stucky-Ropp, J. Hewett, Jane Johnson, Gail Wright, W. Irvin, S. Walker (1995)
Effects of stress management on clinical outcomes in rheumatoid arthritis.Arthritis and rheumatism, 38 12
D. Heijde, M. Breban, D. Halter, G. Divittorio, J. Bratt, F. Cantini, S. Kary, A. Pangan, H. Kupper, S. Rathmann, J. Sieper, P. Mease (2014)
Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumabRheumatology (Oxford, England), 54
Y. el-Miedany, A. El-Rasheed (2002)
Is anxiety a more common disorder than depression in rheumatoid arthritis?Joint, bone, spine : revue du rhumatisme, 69 3
W. Maksymowych, K. Gooch, R. Wong, H. Kupper, D. Heijde (2010)
Impact of Age, Sex, Physical Function, Health-related Quality of Life, and Treatment with Adalimumab on Work Status and Work Productivity of Patients with Ankylosing SpondylitisThe Journal of Rheumatology, 37
J. Isaacs (2015)
Decade in review—clinical rheumatology: 10 years of therapeutic advances in the rheumatic diseasesNature Reviews Rheumatology, 11
Deidre Devier, G. Pelton, M. Tabert, Xinhua Liu, K. Cuasay, R. Eisenstadt, K. Marder, Y. Stern, D. Devanand (2009)
The impact of anxiety on conversion from mild cognitive impairment to Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 24
R. Horne, J. Weinman (1999)
Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness.Journal of psychosomatic research, 47 6
Kari Kvaal, J. Macijauskiene, K. Engedal, K. Laake (2001)
High prevalence of anxiety symptoms in hospitalized geriatric patientsInternational Journal of Geriatric Psychiatry, 16
Turkey Drugs and Medical Devices: Ministry of Health, Republic of Turkey
A. Strangfeld, F. Hierse, R. Rau, G. Burmester, B. Krummel-Lorenz, W. Demary, J. Listing, A. Zink (2010)
Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBITArthritis Research & Therapy, 12
L. Fraenkel, S. Bogardus, J. Concato, D. Felson (2002)
Unwillingness of rheumatoid arthritis patients to risk adverse effects.Rheumatology, 41 3
(1994)
Stress and Anxiety Scales and Sociometric
P. Arkell, S. Ryan, A. Brownfield, A. Cadwgan, J. Packham (2013)
Patient experiences, attitudes and expectations towards receiving information about anti-TNF medication – “It could give me two heads and I’d still try it!”BMC Musculoskeletal Disorders, 14
M. Lader, M. Bruce (1986)
States of anxiety and their induction by drugs.British journal of clinical pharmacology, 22 3
H. Wittchen, R. Kessler, H. Pfister, M. Höfler, R. Lieb (2000)
Why do people with anxiety disorders become depressed? A prospective‐longitudinal community studyActa Psychiatrica Scandinavica, 102
H. Xiong (2014)
Anxiety is an independent predictor of disease activity at three months after initiating treatment with disease modifying antu-rheumatic drugs (DMARDs) in early arthritis patients
J. Singh, G. Wells, R. Christensen, Elizabeth Ghogomu, L. Maxwell, J. Macdonald, G. Filippini, N. Skoetz, Damian Francis, L. Lopes, G. Guyatt, J. Schmitt, L. Mantia, T. Weberschock, J. Roos, Hendrik Siebert, Sarah. Hershan, M. Lunn, P. Tugwell, R. Buchbinder (2011)
Adverse effects of biologics: a network meta-analysis and Cochrane overview.The Cochrane database of systematic reviews, 2
B. Löwe, L. Willand, W. Eich, S. Zipfel, A. Ho, W. Herzog, C. Fiehn (2004)
Psychiatric Comorbidity and Work Disability in Patients With Inflammatory Rheumatic DiseasesPsychosomatic Medicine, 66
C. Tuğlu, S. Kara, O. Çalıyurt, E. Vardar, E. Abay (2003)
Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorderPsychopharmacology, 170
D. Miranda, Taís Lima, Lucas Azevedo, O. Féres, J. Rocha, G. Pereira-da-Silva (2014)
Proinflammatory Cytokines Correlate with Depression and Anxiety in Colorectal Cancer PatientsBioMed Research International, 2014
J. Parker, K. Smarr, J. Slaughter, S. Johnston, M. Priesmeyer, K. Hanson, Gail Johnson, J. Hewett, J. Hewett, W. Irvin, G. Komatireddy, S. Walker (2003)
Management of depression in rheumatoid arthritis: a combined pharmacologic and cognitive-behavioral approach.Arthritis and rheumatism, 49 6
J. Stockdale, Lynne Goodacre (2009)
'It's magic stuff': the experiences of patients with ankylosing spondylitis taking anti-TNF-alpha medication.Musculoskeletal care, 7 3
C. Spielberger, R. Gorsuch, R. Lushene (1970)
Manual for the State-Trait Anxiety Inventory
B. O'Brien, J. Elswood, A. Calin (1990)
Perception of prescription drug risks: a survey of patients with ankylosing spondylitis.The Journal of rheumatology, 17 4
C. Bowen, C. Edwards, L. Hooper, K. Dewbury, M. Sampson, S. Sawyer, J. Burridge, Nigel Arden (2010)
Improvement in symptoms and signs in the forefoot of patients with rheumatoid arthritis treated with anti-TNF therapyJournal of Foot and Ankle Research, 3
P. Anyfanti, E. Gavriilaki, A. Pyrpasopoulou, G. Triantafyllou, A. Triantafyllou, S. Chatzimichailidou, E. Gkaliagkousi, S. Aslanidis, S. Douma (2016)
Depression, anxiety, and quality of life in a large cohort of patients with rheumatic diseases: common, yet undertreatedClinical Rheumatology, 35
Shlomo Cohen (2014)
The Nocebo Effect of Informed ConsentPublic Health Law & Policy eJournal
Natalia Ribeiro, Alexandre Schier, A. Ornelas, Christina Oliveira, A. Nardi, A. Silva (2013)
Anxiety, depression and suicidal ideation in patients with rheumatoid arthritis in use of methotrexate, hydroxychloroquine, leflunomide and biological drugs.Comprehensive psychiatry, 54 8
O. Arisoy, C. Beş, Ç. Çifçi, M. Sercan, M. Soy (2013)
The effect of TNF-alpha blockers on psychometric measures in ankylosing spondylitis patients: a preliminary observationRheumatology International, 33
S. Vinker, Vered Eliyahu, J. Yaphe (2007)
The effect of drug information leaflets on patient behavior.The Israel Medical Association journal : IMAJ, 9 5
F. Uguz, Cemal Akman, Seher Kuçuksaraç, O. Tufekci (2009)
Anti‐tumor necrosis factor‐α therapy is associated with less frequent mood and anxiety disorders in patients with rheumatoid arthritisPsychiatry and Clinical Neurosciences, 63
Dewey Ziegler, Michael Mosier, Maritza Buenaver, Kola Okuyemi (2001)
How much information about adverse effects of medication do patients want from physicians?Archives of internal medicine, 161 5
D. Berry, T. Gillie, S. Banbury (1995)
What do patients want to know: An empirical approach to explanation generation and validationExpert Systems With Applications, 8
Janet Williams (2013)
Diagnostic and Statistical Manual of Mental Disorders
C. Teutsch (2003)
Patient-doctor communication.The Medical clinics of North America, 87 5
International Journal of Rheumatic Diseases – Wiley
Published: Jan 1, 2018
Keywords: ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.